← Back to all trials
Recruiting
NCT06147960
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
Conditions: Cancer of Cervix, Apoptosis
Sex: Female
Ages: 18 Years – N/A
Enrollment: 180
Sponsor: Centre Hospitalier Universitaire de Nīmes
Location: CHU de Nîmes Nîmes Gard
Summary
Overexpression of inhibitors of apoptosis proteins (IAPs) in patients treated for locally advanced cervical cancer with exclusive radio-chemotherapy may have a prognostic role on the local recurrence rate at 24 months.
Eligibility Criteria
Inclusion Criteria:
* Patients treated with the exclusive radio-chemotherapy combination for locally advanced cervical carcinoma (stage Ib-IVb according to FIGO classification).
* Patients aged ≥ 18 years.
* Patients with a minimum of 2 years post-treatment follow-up.
* Patients for whom the initial biopsy specimen (before treatment) is available.
* Patients who have not indicated that they do not wish to participate in the study.
* Patients affiliated to or benefiting from a health insurance scheme.
Exclusion Criteria:
* Patients under court protection, guardianship or curatorship.
Source: ClinicalTrials.gov (NCT06147960). StuddyBuddy aggregates publicly available trial information.